241 related articles for article (PubMed ID: 10458226)
21. Hormone replacement therapy and the breast.
Dixon JM
Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
[TBL] [Abstract][Full Text] [Related]
22. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
Shintani M
Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
[TBL] [Abstract][Full Text] [Related]
23. [Specific estrogen receptor modulators (SERMs)].
Trémollières F; Lopes P
Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
[TBL] [Abstract][Full Text] [Related]
24. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
Emons G; Westphalen S
MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
[TBL] [Abstract][Full Text] [Related]
25. Safety of menopausal hormone therapy in breast cancer survivors older than fifty at diagnosis: A systematic review and meta-analysis.
Mudhune GH; Armour M; McBride KA
Breast; 2019 Oct; 47():43-55. PubMed ID: 31344603
[TBL] [Abstract][Full Text] [Related]
26. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Deli T; Orosz M; Jakab A
Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy in breast cancer patients and survivors.
Del Priore G; Hatami M
Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
[TBL] [Abstract][Full Text] [Related]
28. Risks and benefits of long-term hormone replacement therapy.
Biscup P
Am J Health Syst Pharm; 2003 Jul; 60(14):1419-25. PubMed ID: 12892026
[TBL] [Abstract][Full Text] [Related]
29. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
[TBL] [Abstract][Full Text] [Related]
30. Management of menopausal symptoms in the cancer patient.
Castiel M
Oncology (Williston Park); 1999 Oct; 13(10):1363-72; discussion 1372, 1377-83. PubMed ID: 10549564
[TBL] [Abstract][Full Text] [Related]
31. Current issues in hormone replacement therapy.
Timins JK
N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
[TBL] [Abstract][Full Text] [Related]
32. Post-menopausal women and osteoporosis: available choices for maintenance of skeletal health.
Termine JD; Wong M
Maturitas; 1998 Nov; 30(3):241-5. PubMed ID: 9881323
[TBL] [Abstract][Full Text] [Related]
33. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy in cancer survivors: Utopia?
Angioli R; Luvero D; Armento G; Capriglione S; Plotti F; Scaletta G; Lopez S; Montera R; Gatti A; Serra GB; Benedetti Panici P; Terranova C
Crit Rev Oncol Hematol; 2018 Apr; 124():51-60. PubMed ID: 29548486
[TBL] [Abstract][Full Text] [Related]
35. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
36. The controversy of hormone-replacement therapy in breast cancer survivors.
Snyder GM; Sielsch EC; Reville B
Oncol Nurs Forum; 1998 May; 25(4):699-706; quiz 707-8. PubMed ID: 9599353
[TBL] [Abstract][Full Text] [Related]
37. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy in postmenopausal women.
Staren ED; Omer S
Am J Surg; 2004 Aug; 188(2):136-49. PubMed ID: 15249239
[TBL] [Abstract][Full Text] [Related]
39. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
Trinh XB; Peeters F; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk.
Col NF; Hirota LK; Orr RK; Erban JK; Wong JB; Lau J
J Clin Oncol; 2001 Apr; 19(8):2357-63. PubMed ID: 11304788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
